batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Surprise win for Corcept's glucocorticoid therapy 31 March 2025 Enhertu targets HER2-positive lung again 31 March 2025 German Merck makes SpringWorks holders squirm 28 March 2025 Another Sanofi setback for Innate 27 March 2025 ELCC 2025 – AstraZeneca gets a survival boost from Laura 25 March 2025 Eisai says no to HER2 24 March 2025 Century turns away from natural killer cells 20 March 2025 Hutchmed looks for another fruquintinib use 19 March 2025 Load More